Furthermore, using a ferroptosis inhibitor, we showed that ferroptosis significantly aggravated NASH and noted that this was likely achieved by regulation of the expression of peroxisome proliferator activated receptor (PPAR)α. This evidence concerns the gene PPARA and metabolic dysfunction-associated steatohepatitis.